But physician groups asked the FDA to pause the launching of the
written document because of complaints of long waits on a call-in line
and a rule requiring women to receive pregnancy test results no more
than a week after get together with a Doctor.
“It puts too much authorities between patients and physicians,” Clay
Cockerell, MD, chairperson of the American language Institution of
Dermatology, tells WebMD.
An estimated 30,000 physicians have
already signed on with the registry to be eligible to prescribe
isotretinoin.
Less than 30,000 patients are estimated to have signed up with iPledge,
which is animate thing run by Covance, Inc., a drug services troupe.
But
Cockerell says dermatologists are already keenly aware of
isotretinoin’s risks and that the software program won’t prevent
patients from judgment the drug on the Internet.
“The face line is, we just don’t think it’s death to work,” he says.
Accutane
is sold by Swiss fellowship Hoffmann-La Roche Inc.
Leash other firms sell the drug in vino forms.
Roche reported to the FDA in 2004 that 183 women took the drug while
pregnant during its earlier tracking written document, compared with
150 in the year before.
Vino manufacturers reported 19 more cases since December 2007 while
using identical tracking programs.
This is a part of article Acne Drug Restrictions Fuel Debate Part 3 Taken from "Isotretinoin Accutane Side Effects" Information Blog
No comments:
Post a Comment